Inhibition of the NRF2/KEAP1 Axis: A Promising Therapeutic Strategy to Alter Redox Balance of Cancer Cells

被引:31
作者
Panieri, Emiliano [1 ]
Saso, Luciano [1 ]
机构
[1] Univ Roma La Sapienza, Dept Physiol & Pharmacol Vittorio Erspamer, I-00185 Rome, Italy
关键词
NRF2-KEAP1; NRF2; inhibitors; reactive oxygen species; oxidative stress; cancer; chemotherapy; redox therapy;
D O I
10.1089/ars.2020.8146
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Significance: The nuclear factor erythroid 2-related factor 2/Kelch-like ECH-associated protein 1 (NRF2/KEAP1) pathway is a crucial and highly conserved defensive system that is required to maintain or restore the intracellular homeostasis in response to oxidative, electrophilic, and other types of stress conditions. The tight control of NRF2 function is maintained by a complex network of biological interactions between positive and negative regulators that ultimately ensure context-specific activation, culminating in the NRF2-driven transcription of cytoprotective genes. Recent Advances: Recent studies indicate that deregulated NRF2 activation is a frequent event in malignant tumors, wherein it is associated with metabolic reprogramming, increased antioxidant capacity, chemoresistance, and poor clinical outcome. On the other hand, the growing interest in the modulation of the cancer cells' redox balance identified NRF2 as an ideal therapeutic target. Critical Issues: For this reason, many efforts have been made to identify potent and selective NRF2 inhibitors that might be used as single agents or adjuvants of anticancer drugs with redox disrupting properties. Despite the lack of specific NRF2 inhibitors still represents a major clinical hurdle, the researchers have exploited alternative strategies to disrupt NRF2 signaling at different levels of its biological activation. Future Directions: Given its dualistic role in tumor initiation and progression, the identification of the appropriate biological context of NRF2 activation and the specific clinicopathological features of patients cohorts wherein its inactivation is expected to have clinical benefits, will represent a major goal in the field of cancer research. In this review, we will briefly describe the structure and function of the NRF2/ KEAP1 system and some of the most promising NRF2 inhibitors, with a particular emphasis on natural compounds and drug repurposing.
引用
收藏
页码:1428 / 1483
页数:56
相关论文
共 50 条
  • [31] Keap1/Nrf2/ARE redox-sensitive signaling system as a pharmacological target
    N. K. Zenkov
    E. B. Menshchikova
    V. O. Tkachev
    Biochemistry (Moscow), 2013, 78 : 19 - 36
  • [32] The cytoprotective role of the Keap1–Nrf2 pathway
    Liam Baird
    Albena T. Dinkova-Kostova
    Archives of Toxicology, 2011, 85 : 241 - 272
  • [33] Beyond repression of Nrf2: An update on Keap1
    Kopacz, Aleksandra
    Kloska, Damian
    Forman, Henry Jay
    Jozkowicz, Alicja
    Grochot-Przeczek, Anna
    FREE RADICAL BIOLOGY AND MEDICINE, 2020, 157 : 63 - 74
  • [34] Modulation of NRF2/KEAP1 Signaling in Preeclampsia
    Tossetta, Giovanni
    Fantone, Sonia
    Piani, Federica
    Crescimanno, Caterina
    Ciavattini, Andrea
    Giannubilo, Stefano Raffaele
    Marzioni, Daniela
    CELLS, 2023, 12 (11)
  • [35] Structural basis of Keap1 interactions with Nrf2
    Canning, Peter
    Sorrell, Fiona J.
    Bullock, Alex N.
    FREE RADICAL BIOLOGY AND MEDICINE, 2015, 88 : 101 - 107
  • [36] Mechanism of the Nrf2/Keap1/ARE signaling system
    V. O. Tkachev
    E. B. Menshchikova
    N. K. Zenkov
    Biochemistry (Moscow), 2011, 76 : 407 - 422
  • [37] Role of Natural and Synthetic Compounds in Modulating NRF2/KEAP1 Signaling Pathway in Prostate Cancer
    Tossetta, Giovanni
    Fantone, Sonia
    Marzioni, Daniela
    Mazzucchelli, Roberta
    CANCERS, 2023, 15 (11)
  • [38] Pterostilbene-mediated Nrf2 activation: Mechanistic insights on Keap1:Nrf2 interface
    Bhakkiyalakshmi, Elango
    Dineshkumar, Kesavan
    Karthik, Suresh
    Sireesh, Dornadula
    Hopper, Waheeta
    Paulmurugan, Ramasamy
    Ramkumar, Kunka Mohanram
    BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (16) : 3378 - 3386
  • [39] Activation of Keap1/Nrf2 signaling pathway by nuclear epidermal growth factor receptor in cancer cells
    Huo, Longfei
    Li, Chia-Wei
    Huang, Tzu-Hsuan
    Lam, Yung Carmen
    Xia, Weiya
    Tu, Chun
    Chang, Wei-Chao
    Hsu, Jennifer L.
    Lee, Dung-Fang
    Nie, Lei
    Yamaguchi, Hirohito
    Wang, Yan
    Lang, Jingyu
    Li, Long-Yuan
    Chen, Chung-Hsuan
    Mishra, Lopa
    Hung, Mien-Chie
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2014, 6 (06): : 649 - 663
  • [40] The Role of the Keap1/Nrf2 Pathway in the Cellular Response to Methylmercury
    Kumagai, Yoshito
    Kanda, Hironori
    Shinkai, Yasuhiro
    Toyama, Takashi
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2013, 2013